# EDGAR Filing Document

**Accession Number:** 0002079897
**File Stem:** 0001213900-25-072737
**Filing Date:** 2025-8
**Character Count:** 19153
**Document Hash:** ab33c31abcf392b0d65c90fa6271f2e9
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001213900-25-072737.hdr.sgml**: 20250806

**ACCESSION NUMBER**: 0001213900-25-072737

**CONFORMED SUBMISSION TYPE**: SCHEDULE 13D

**PUBLIC DOCUMENT COUNT**: 2

**FILED AS OF DATE**: 20250806

**DATE AS OF CHANGE**: 20250806

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Aureus Greenway Holdings Inc
- **CENTRAL INDEX KEY:** 0002009312
- **STANDARD INDUSTRIAL CLASSIFICATION:** SERVICES-MEMBERSHIP SPORTS & RECREATION CLUBS [7997]
- **ORGANIZATION NAME:** 07 Trade & Services
- **EIN:** 990418678
- **STATE OF INCORPORATION:** NV
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-94973
- **FILM NUMBER:** 251191183

**BUSINESS ADDRESS:**
- **STREET 1:** 2995 REMINGTON BLVD
- **CITY:** KISSIMMEE
- **STATE:** FL
- **ZIP:** 34744
- **BUSINESS PHONE:** 1-914-843-1982

**MAIL ADDRESS:**
- **STREET 1:** 2995 REMINGTON BLVD
- **CITY:** KISSIMMEE
- **STATE:** FL
- **ZIP:** 34744
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Steven Scopellite 2021 IRR
- **CENTRAL INDEX KEY:** 0002079897

**ORGANIZATION NAME:**
- **EIN:** 866571009
- **STATE OF INCORPORATION:** NJ
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SCHEDULE 13D

**BUSINESS ADDRESS:**
- **STREET 1:** 11 WHARF AVENUE
- **STREET 2:** SUITE C3
- **CITY:** RED BANK
- **STATE:** NJ
- **ZIP:** 07701
- **BUSINESS PHONE:** 732-354-1951

**MAIL ADDRESS:**
- **STREET 1:** 11 WHARF AVENUE
- **STREET 2:** SUITE C3
- **CITY:** RED BANK
- **STATE:** NJ
- **ZIP:** 07701

## Ex-1.A

**Exhibit A**

**JOINT FILING AGREEMENT**

Pursuant to and in accordance with the Securities Exchange Act of 1934, as amended, and the rules and regulations thereunder (the "<u>Exchange Act</u>") the undersigned hereby agree to the joint filing on behalf of each of them of any filing required by such party under Section 13 of the Exchange Act or any rule or regulation thereunder (including any amendment, restatement, supplement, and/or exhibit thereto) with respect to securities of Aureus Greenway Holdings Inc., a Nevada corporation, and further agree to the filing, furnishing, and/or incorporation by reference of this Agreement as an exhibit thereto. Each of them is responsible for the timely filing of such filings and any amendments thereto, and for the completeness and accuracy of the information concerning such person contained therein; but none of them is responsible for the completeness or accuracy of the information concerning the other persons making the filing, unless such person knows or has reason to believe that such information is inaccurate. This Agreement shall remain in full force and effect until revoked by any party hereto in a signed writing provided to each other party hereto, and then only with respect to such revoking party. This Agreement may be executed in any number of counterparts all of which taken together shall constitute one and the same instrument.

Dated: August 6, 2025

---

| | |
|:---|:---|
| **The Steven Scopellite 2021 IRR** | **The Steven Scopellite 2021 IRR** |
| By: | /s/ Michael Canarick |
| Name: | Michael Canarick |
| Title: | Trustee |
| **Michael Canarick** | **Michael Canarick** |
| By: | /s/ Michael Canarick |
| Name: | Michael Canarick |
| **Steven Scopellite** | **Steven Scopellite** |
| By: | /s/ Steven Scopellite |
| Name: | Steven Scopellite |

---

### UNITED STATES SECURITIES AND EXCHANGE COMMISSION
**Washington, D.C. 20549**

## SCHEDULE 13D

### Under the Securities Exchange Act of 1934

**Aureus Greenway Holdings Inc.**

*(Name of Issuer)*

**Common Stock, par value $0.001 per share**

*(Title of Class of Securities)*

**05156D102**

*(CUSIP Number)*

**Michael Canarick**<br>The Steven Scopellite 2021 IRR<br>11 Wharf Avenue, Suite C3<br>Red Bank NJ 07701<br>(813) 482-2999

*(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)*

**07/25/2025**

*(Date of Event Which Requires Filing of this Statement)*

| **CUSIP No.** | **05156D102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**The Steven Scopellite 2021 IRR** | Name of reporting person<br>**The Steven Scopellite 2021 IRR** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**PF** | Source of funds (See Instructions)<br>**PF** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**650000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**650000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.4%** | Percent of class represented by amount in Row (11)<br>**4.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**OO** | Type of Reporting Person (See Instructions)<br>**OO** | |

---

**Comment for Reporting Person:** (1) The number of shares in Rows 8, 10 and 11 represents 650,000 shares of common stock, par value $0.001 per share (the "Common Stock"), of Aureus Greenway Holdings Inc. (the "Issuer"), held by The Steven Scopellite 2021 IRR (the "Trust"). Michael Canarick is the trustee of the Trust. As trustee, Michael Canarick exercises voting and investment control over the securities held by the Trust. Steven Scopellite, as grantor of the Trust, may be deemed to share voting and dispositive power over the securities held by the Trust with the trustee, Michael Canarick. Each disclaims beneficial ownership of the securities held by the Trust except to the extent of their respective pecuniary interests.

(2) The Trust also holds 10,000,000 shares of Series A Preferred Stock, par value $0.001 per share (the "Preferred Stock"), which are not convertible into common stock. Each share of the Preferred Stock entitles the Trust to votes equal to twenty (20) votes per share of Preferred Stock held.

(3) The reported beneficial ownership percentage in Row 13 is based on 14,608,988 shares of Common Stock as reported in the Issuer's Form S-1 filed with the Securities and Exchange Commission on August 4, 2025.

(4) The Trust is the sole holder of all issued and outstanding shares of Preferred Stock and after giving effect to the voting rights of such Preferred Stock and the voting rights of the Common Stock beneficially owned by the Trust, the aggregate voting power held by the Trust would be 93.5% of all voting rights of the Issuer's voting securities (based on 214,608,988 aggregate votes).

| **CUSIP No.** | **05156D102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Michael Canarick** | Name of reporting person<br>**Michael Canarick** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**650000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**650000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.4%** | Percent of class represented by amount in Row (11)<br>**4.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) The number of shares in Rows 8, 10 and 11 represents 650,000 shares of Common Stock of the Issuer, held by the Trust. Michael Canarick is the trustee of the Trust. As trustee, Michael Canarick exercises voting and investment control over the securities held by the Trust. Steven Scopellite, as grantor of the Trust, may be deemed to share voting and dispositive power over the securities held by the Trust with the trustee, Michael Canarick. Each disclaims beneficial ownership of the securities held by the Trust except to the extent of their respective pecuniary interests.

2) The Trust also holds 10,000,000 shares of Series A Preferred Stock, which are not convertible into common stock. Each share of the Preferred Stock entitles the Trust to votes equal to twenty (20) votes per share of Preferred Stock held.

(3) The reported beneficial ownership percentage in Row 13 is based on 14,608,988 shares of Common Stock as reported in the Issuer's Form S-1 filed with the Securities and Exchange Commission on August 4, 2025.

(4) The Trust is the sole holder of all issued and outstanding shares of Preferred Stock and after giving effect to the voting rights of such Preferred Stock and the voting rights of the Common Stock beneficially owned by the Trust, the aggregate voting power held by the Trust would be 93.5% of all voting rights of the Issuer's voting securities (based on 214,608,988 aggregate votes).

| **CUSIP No.** | **05156D102** |

---

| | | | |
|:--|:--|:--|:--|
| 1 | Name of reporting person<br>**Steven Scopellite** | Name of reporting person<br>**Steven Scopellite** | |
| 2 | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | Check the appropriate box if a member of a Group (See Instructions)<br>[x] (a)<br>[ ] (b) | |
| 3 | SEC use only | SEC use only | |
| 4 | Source of funds (See Instructions)<br>**OO** | Source of funds (See Instructions)<br>**OO** | |
| 5 | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)<br>[ ] | |
| 6 | Citizenship or place of organization<br>**X1** | Citizenship or place of organization<br>**X1** | |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 7 | Sole Voting Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 8 | Shared Voting Power<br>**650000.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 9 | Sole Dispositive Power<br>**0.00** |
| Number of Shares<br>Beneficially Owned by<br>Each Reporting Person With: | 10 | Shared Dispositive Power<br>**650000.00** |
| 11 | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | Aggregate amount beneficially owned by each reporting person<br>**650000.00** | |
| 12 | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | Check if the aggregate amount in Row (11) excludes certain shares (See Instructions)<br>[ ] | |
| 13 | Percent of class represented by amount in Row (11)<br>**4.4%** | Percent of class represented by amount in Row (11)<br>**4.4%** | |
| 14 | Type of Reporting Person (See Instructions)<br>**IN** | Type of Reporting Person (See Instructions)<br>**IN** | |

---

**Comment for Reporting Person:** (1) The number of shares in Rows 8, 10 and 11 represents 650,000 shares of Common Stock of the Issuer, held by the Trust. Michael Canarick is the trustee of the Trust. As trustee, Michael Canarick exercises voting and investment control over the securities held by the Trust. Steven Scopellite, as grantor of the Trust, may be deemed to share voting and dispositive power over the securities held by the Trust with the trustee, Michael Canarick. Each disclaims beneficial ownership of the securities held by the Trust except to the extent of their respective pecuniary interests.

(2) The Trust also holds 10,000,000 shares of Series A Preferred Stock, which are not convertible into common stock. Each share of the Preferred Stock entitles the Trust to votes equal to twenty (20) votes per share of Preferred Stock held.

(3) The reported beneficial ownership percentage in Row 13 is based on 14,608,988 shares of Common Stock as reported in the Issuer's Form S-1 filed with the Securities and Exchange Commission on August 4, 2025.

(4) The Trust is the sole holder of all issued and outstanding shares of Preferred Stock and after giving effect to the voting rights of such Preferred Stock and the voting rights of the Common Stock beneficially owned by the Trust, the aggregate voting power held by the Trust would be 93.5% of all voting rights of the Issuer's voting securities (based on 214,608,988 aggregate votes).

**Item 1. Security and Issuer**

**(a) Title of Class of Securities:**
Common Stock, par value $0.001 per share

**(b) Name of Issuer:**
Aureus Greenway Holdings Inc.

**(c) Address of Issuer's Principal Executive Offices:**
2995 Remington Boulevard, Kissimmee, FL, 34744

**Item 4. Purpose of Transaction**

The Steven Scopellite 2021 IRR acquired beneficial ownership of the securities reported herein for investment purposes. The Reporting Person's do not have any current plans or proposals which would result in any of the matters listed in Item 4(a) - (j) of Schedule 13D.

**Item 5. Interest in Securities of the Issuer**

**(a)**
The Trust owns 650,000 shares of common stock. Michael Canarick is the trustee of the Trust. As trustee, Michael Canarick exercises voting and investment control over the securities held by the Trust. Steven Scopellite, as grantor of the Trust, may be deemed to share voting and dispositive power over the securities held by the Trust with the trustee, Michael Canarick. Each disclaims beneficial ownership of the securities held by the Trust except to the extent of their respective pecuniary interests.

The Trust also holds 10,000,000 shares of Series A Preferred Stock, which are not convertible into common stock. Each share of the Preferred Stock entitles the Trust to votes equal to twenty (20) votes per share of Preferred Stock held.

The reported beneficial ownership percentage in Row 13 is based on 14,608,988 shares of Common Stock as reported in the Issuer's Form S-1 filed with the Securities and Exchange Commission on August 4, 2025.

The Trust is the sole holder of all issued and outstanding shares of Preferred Stock and after giving effect to the voting rights of such Preferred Stock and the voting rights of the Common Stock beneficially owned by the Trust, the aggregate voting power held by the Trust would be 93.5% of all voting rights of the Issuer's voting securities (based on 214,608,988 aggregate votes).

**(b)**
The Trust owns 650,000 shares of common stock. Michael Canarick is the trustee of the Trust. As trustee, Michael Canarick exercises voting and investment control over the securities held by the Trust. Steven Scopellite, as grantor of the Trust, may be deemed to share voting and dispositive power over the securities held by the Trust with the trustee, Michael Canarick. Each disclaims beneficial ownership of the securities held by the Trust except to the extent of their respective pecuniary interests.

The Trust also holds 10,000,000 shares of Series A Preferred Stock, par value $0.001 per share (the "Preferred Stock"), which are not convertible into common stock. Each share of the Preferred Stock entitles the Trust to votes equal to twenty (20) votes per share of Preferred Stock held.

The reported beneficial ownership percentage in Row 13 is based on 14,608,988 shares of Common Stock as reported in the Issuer's Form S-1 filed with the Securities and Exchange Commission on August 4, 2025.

The Trust is the sole holder of all issued and outstanding shares of Preferred Stock and after giving effect to the voting rights of such Preferred Stock and the voting rights of the Common Stock beneficially owned by the Trust, the aggregate voting power held by the Trust would be 93.5% of all voting rights of the Issuer's voting securities (based on 214,608,988 aggregate votes).

**(c)**
There have been no transactions in the class of securities reported on that were effected within the past 60 days.

**Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.**

There are no contracts, arrangements, understandings or relationships among the Reporting Persons, or between the Reporting Persons and any other person, with respect to the securities of the Issuer.

### SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** The Steven Scopellite 2021 IRR

**Signature:** /s/ Michael Canarick

**Name/Title:** Michael Canarick/Trustee

**Date:** 08/06/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Michael Canarick

**Signature:** /s/ Michael Canarick

**Name/Title:** Michael Canarick/Trustee

**Date:** 08/06/2025

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

**Reporting Person:** Steven Scopellite

**Signature:** /s/ Steven Scopellite

**Name/Title:** Steven Scopellite

**Date:** 08/06/2025